{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "EPAM",
  "name": "EPAM SYSTEMS, INC.",
  "url": "https://frontierpicks.com/dossiers/EPAM/",
  "json_url": "https://frontierpicks.com/dossiers/EPAM.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": "LOW",
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Compounder narrative broken on 2026-08-06: FY26 organic constant-currency growth cut to 2.0%–3.0%, Q3 guided to ~1.7% YoY. Price has stalled rather than extended lower ($99.90 close 2026-08-11 vs $97.43 on 2026-08-07), but the AI-native replacement ($160M in Q2, >11% of revenue) gets no dated proof until the ~November Q3 print.",
  "invalidation_trigger": "A weekly close below $92 confirms the post-guidance-cut de-rating leg resumed and puts the $73.06 52-week low back in play; secondarily, a Q3 report around 2026-11-05 guiding Q4 organic constant-currency growth below zero would end the stabilisation case.",
  "catalyst_date": null,
  "outcome": "PLAYED_OUT",
  "outcome_date": "2026-08-21",
  "invalidation_fired": false,
  "themes": [
    "cyclical-industrials",
    "managed-care-health-services",
    "ai-datacenter-infrastructure"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "EPAM reports on a calendar fiscal year. As of 2026-08-23 the company had not published a Q3 2026 scheduling release; third-party calendars show ~2026-10-29.",
    "GAAP and non-GAAP guidance diverge widely (FY2026: $8.22-$8.38 GAAP vs $13.08-$13.24 non-GAAP diluted EPS) - check which measure a headline quotes.",
    "No dividend. Capital return runs entirely through repurchases: $85M in Q2 2026 and $409M year-to-date through 2026-06-30.",
    "The $632.49M repurchase program completed in early August 2026 sat under a $1B board authorisation reported as announced 2025-10-21; remaining capacity becomes a filed number in the Q3 10-Q.",
    "Reported revenue growth exceeded organic constant-currency growth in Q2 2026 (4.5% vs 3.4%), so FX flatters the headline revenue line.",
    "Consensus price-target vendors disagree materially - $116.47, $124 and $133.94 were all quoted as of 2026-08-23. Check the panel size before citing one."
  ],
  "body_markdown": "## Current Thesis\n\nThe leg an investor was buying in EPAM — a digital-engineering compounder that turns AI into a larger book of billable work — was repriced on 2026-08-06, when Q2 revenue of $1.415B (+4.5% YoY, +3.4% organic constant currency) and non-GAAP diluted EPS of $3.38 (+22.0% YoY versus a $3.14 estimate) both cleared consensus and the company still cut FY2026 revenue guidance to $5.632B–$5.686B from $5.675B–$5.813B. Organic constant-currency growth went to 2.0%–3.0%; Q3 was guided to $1.410B–$1.425B against $1.445B consensus, roughly 1.7% YoY at the midpoint. CEO Fejes described clients moving budget out of task-based work faster than AI-led replacement work ramps, \"creating a growth gap.\"\n\nWhat has changed since the 2026-08-12 update is entirely price. The stock closed $97.43 on 2026-08-07, $99.90 on 2026-08-11, $107.43 on 2026-08-19 (market capitalisation $5.58B, per ad-hoc-news 2026-08-20) and $110.34 on 2026-08-21. No company disclosure, filing or guidance change landed in that span; the last dated company event remains the 2026-07-28 OpenAI Advanced Partner announcement and the 2026-08-06 print. A roughly two-week recovery off a post-cut low, unaccompanied by new information, is a re-rating of sentiment against an unchanged fact set.\n\nThe narrative is **dead**, and the label refers to the narrative rather than the tape. Dating it: the 2026-08-06 guidance cut, William Blair's same-day downgrade to Market Perform, and a price-target cut sequence that has run since 2026-07-09 and had not stopped as of 2026-08-10 (Mizuho $162→$130; Guggenheim $165→$140, both 2026-08-10). The replacement story is inside the numbers — AI-native revenue of $160M in Q2, above 11% of total, a sixth consecutive quarter of double-digit sequential growth against roughly a $600M annual pace — but management placed meaningful revenue from large AI-driven deals in early 2027 and declined to guide 2027. Nothing dated tests it before the Q3 report.\n\n## Bull Case\n\n- AI-native revenue $160M in Q2 2026, over 11% of total, sixth straight quarter of double-digit sequential growth (Q2 call, 2026-08-06). The roughly $600M annual trajectory survived the top-line cut.\n- FY2026 non-GAAP diluted EPS guidance was narrowed with the low end lifted — $12.98–$13.28 to $13.08–$13.24 against $13.04 consensus — while revenue came down (2026-08-06 release). FY2026 GAAP diluted EPS is guided $8.22–$8.38 on a GAAP operating margin of 10.5%–11.0%.\n- Margin held through the cut: Q2 non-GAAP income from operations 16.4% of revenue, GAAP 10.8% (2026-08-06 release).\n- Financial Services grew 11.5% YoY and Life Sciences & Healthcare 8% YoY in Q2 2026 (Q2 call).\n- Share count is shrinking.\n- Balance sheet funds the transition: cash and equivalents $789.4M, Q2 repurchases $85M, $409M year-to-date through 2026-06-30 (2026-08-06 release).\n- Market capitalisation of $5.58B on 2026-08-19 sits below the guided FY2026 revenue range of $5.632B–$5.686B.\n\n## Bear Case\n\n- The 2026-08-06 cut took FY2026 organic constant-currency growth to 2.0%–3.0%, and Q3 to about 1.7% YoY at the midpoint against $1.445B consensus. The company attributed it to substitution, not a macro pause.\n- Software & Hi-Tech contracted 1.3% YoY in Q2 2026 while Financial Services carried the quarter at +11.5% YoY (Q2 call).\n- Reported revenue growth (4.5%) exceeded organic constant-currency growth (3.4%) in Q2 2026, so FX flatters the headline line.\n- Delivery headcount grew — 62,850 total, 56,650 delivery professionals, +1.5% YoY — against a guided low-single-digit revenue trajectory. Inferred, not disclosed: that combination puts utilisation and pricing on the burden of proof at the Q3 print.\n- The 2026-08-19 close of $107.43 is above Citigroup's $100 target (2026-07-27), Morgan Stanley's $100 (2026-08-04) and Truist's $110 (2026-08-07, cut from $112). Simply Wall St reported the consensus target fell 8.2% to $124 after the Q2 result.\n- The recovery has carried price back toward the levels that produced the July target cuts, without any revision to the guidance those cuts were responding to.\n\n## Setup & Price Structure\n\n- Reference point: the 2026-08-21 close of $110.34, 50.2% below the $221.4 52-week high, with RSI(14) at 53.2 and a three-month price change of +7.4%.\n- The post-print structure is a shelf. The 2026-08-11 session ranged $96.53–$100.70 and closed $99.90 (+2.60%); the low close since the cut is $97.43 on 2026-08-07. Price has since travelled to $107.43 (2026-08-19) and $110.34 (2026-08-21) without revisiting it.\n- RSI at 53.2 after that run is mid-range — the advance has not stretched momentum to an extreme, which cuts both ways: no exhaustion signal, and no confirmation that a trend has established.\n- Positioning observables, stated as observables: no earnings date inside 30 days; a completed buyback program, so the documented repurchase flow that ran at $85M in Q2 has no disclosed continuation until the Q3 10-Q; and a target panel that disagrees with itself — public.com shows a 17-analyst average of $133.94 with a $225 high and an $83 low, Simply Wall St quotes $124, and ad-hoc-news quoted a $116.47 consensus alongside a $113.38 third-party fair-value estimate (all as retrieved 2026-08-23).\n- No insider transactions appear in the filings reviewed for the period since the print.\n\n## Catalyst Calendar (next 30 days)\n\n- **~2026-09-25 (est.)** — Accenture FY Q4 results and FY2027 outlook. Just outside the window; the nearest dated read-across on whether agentic delivery is compressing billable-hour work across IT services broadly.\n- **2026-09-30** — the quarter guided to $1.410B–$1.425B closes. Nothing about that guide is verifiable before this date, and the disclosure arrives a month later.\n- **~2026-10-29 (est.)** — Q3 2026 results and Q4 guidance, per third-party earnings calendars; EPAM had not published a scheduling release as of 2026-08-23 in the material reviewed, and prior-year cadence spans late October to early November.\n- **~2027-02 (est.)** — Q4/FY2026 results with initial FY2027 guidance, where management's claim about large AI-driven deals ramping in early 2027 becomes a number.\n\n## Elapsed catalysts\n\n- **No company-dated event falls inside 30 days of 2026-08-23.** The window is empty by the company's own calendar. *(passed 3d ago)*\n\n## What Would Change Our Mind\n\nThe structure that matters is the $96.53–$100.70 post-cut shelf the August recovery left behind. Give it back and the stabilisation reading is finished: a weekly close below $99 retraces the entire post-guidance-cut bounce and returns the $73.06 52-week low to the frame. On the fundamental side, the substitution thesis stops being an interpretation and becomes a trend if the Q3 report (~2026-10-29 est.) guides Q4 organic constant-currency growth below zero, if the AI-native sequential streak breaks after six quarters, or if Financial Services decelerates out of double-digit YoY growth.\n\nRunning the other way: two consecutive weekly closes above $110.70 with the Q3 print confirming AI-native revenue tracking past the roughly $600M annual pace would make the replacement narrative dated evidence rather than management assertion. A successor repurchase authorisation disclosed with the Q3 10-Q would restore a documented bid that currently has no stated continuation.\n\n## Correlation Notes\n\n- EPAM trades inside the IT-services complex (ACN, CTSH, INFY, WIT, GLOB) and moves with it on days when the whole group re-rates; the 2026-08-19 advance was reported as occurring alongside a sector-wide rally (AlphaStreet), which argues part of the recovery is group beta rather than name-specific.\n- The name is the negative-facing leg of the AI-labour trade: the same agentic-delivery story that supports AI infrastructure spending is the mechanism management cited for its own growth gap. Correlation to AI-infrastructure winners can be inverse on narrative days.\n- FX is a live second-order driver — reported growth of 4.5% against 3.4% organic constant currency in Q2 2026 means a weaker dollar flatters the print and a stronger one compounds the guided deceleration.\n- Accenture's late-September fiscal Q4 is the closest scheduled peer disclosure and will generalise or narrow the substitution mechanism before EPAM reports.",
  "first_seen": "2026-07-30",
  "last_analyzed": "2026-08-23T11:40:50+00:00",
  "last_synthesized": "2026-08-23",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}